WuXi Biologics IPO Review - An Opportunity to Get Exposure to Biologics in China
WuXi Biologics (2269 HK) is looking to raise US$461-511m through the issuance of primary (88%) and secondary (12%) shares. Â Proceeds will be used...
1k Views
HONMA Golf - Call with CFO to Follow up on IPO, 1H2016 Results and Growth
We recently spoke to the Honma's CFO, Ms. Bian, to clarify some concerns from investors, recent performance and growth going forward.Updates since...
547 Views
Smartkarma - ECM Coverage Weekly Update (10 Oct 2016)
Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...
371 Views
Acushnet (GOLF) Receives the Approval for an IPO in the US
According to Hankyung Korean daily, it was reported that Acushnet received the final approval by the Securities & Exchange Commission (US)...
549 Views
Smartkarma - ECM Coverage Weekly Update (3 Oct 2016)
Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...
358 Views